INHIBITION OF 53BP1: POTENTIAL FOR RESTORING HOMOLOGOUS RECOMBINATION IN OVARIAN CANCER CELLS

$397,500FY2016Department of DefenseDOD

Mayo Clinic, Rochester MN

Investigators

View source on USAspending →